The Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with a large footprint in manufacturing and training in India, recently hosted a high–level meeting with international delegates, government stakeholders, and MedTech industry captains at Shangri-La, New Delhi. 

The event was graced by Aseem Sahu, Deputy Drugs Controller, Central Drugs Standard Control Organisation (CDSCO), and Abby Pratt, Senior Vice President, Advanced Medical Technology Association (AdvaMed).

The discussion revolved around opportunities and current challenges within the MedTech domain including tariff and non-tariff barriers, friend-shoring opportunities, and streamlining of the regulations. Several strategic discussions also took place aiming to promote India as an attractive destination for investments from global as well as domestic players.

During the event, the Deputy Drugs Controller stated that quality and patient safety are at the centre of any policy or related decisions that the government makes and is already working towards global harmonisation of standards, capacity building, and promoting innovation in MedTech space.

Speaking at the event, Pavan Choudary, Chairman, MTaI stated, “We feel that domestic and international currents will together help carve out key policy recommendations which will be instrumental in furthering the MedTech industry in India."

Adding to Choudary’s views, Abby Pratt, Senior Vice President, AdvaMed stated, “I really appreciate for this vital dialogue on the importance of harmonized regulations and global consensus standards. It is also reassuring to see the inclusive approach of the government to consult with industry on policy matters and regulations and offering association's cooperation to the government. The government-industry discourse underscores India's intent and its potential to emerge as a key player in the global MedTech arena."

Image caption- L-R- Sanjeev Sawhney, Managing Director, Medskin Suwelack; Abby Pratt, Senior Vice President, AdvaMed; Pavan Choudary, Chairman, MTaI; Aseem Sahu, Deputy Drugs Controller, CDSCO; Sanjay Bhutani, Managing Director, Bausch & Lomb India; and Nitesh Piplani, CEO, Steris India